肿瘤辐射吸收剂量与反应之间的相关性在先前未接受过治疗的患者中更容易发现。 - Suppr

Suppr

超能文献

Correlation of tumor radiation-absorbed dose with response is easier to find in previously untreated patients.

作者信息

Koral Kenneth F, Kaminski Mark S, Wahl Richard L

出版信息

J Nucl Med. 2003 Sep;44(9):1541-3; author reply 1543.

PMID:12960205

Abstract

摘要

相似文献

Correlation of tumor radiation-absorbed dose with response is easier to find in previously untreated patients.肿瘤辐射吸收剂量与反应之间的相关性在先前未接受过治疗的患者中更容易发现。

J Nucl Med. 2003 Sep;44(9):1541-3; author reply 1543.

Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.131I-抗B1抗体治疗的非霍奇金淋巴瘤患者的个体化三维剂量测定：肿瘤剂量反应评估

J Nucl Med. 2003 Feb;44(2):260-8.

Impact of nodal regression on radiation dose for lymphoma patients after radioimmunotherapy.放射免疫治疗后淋巴瘤患者淋巴结消退对辐射剂量的影响。

J Nucl Med. 2003 Aug;44(8):1322-9.

High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.高剂量（131）I-托西莫单抗（抗CD20）放射免疫疗法治疗非霍奇金淋巴瘤：根据实际器官体积调整辐射吸收剂量。

J Nucl Med. 2004 Jun;45(6):1059-64.

Comparisons of dosimetric approaches for fractionated radioimmunotherapy of non-Hodgkin lymphoma.非霍奇金淋巴瘤分次放射免疫治疗剂量学方法的比较。

Q J Nucl Med Mol Imaging. 2012 Dec;56(6):529-37.

Bias reduction in correlation of radiation-absorbed dose with response.减少辐射吸收剂量与反应相关性中的偏差。

J Nucl Med. 2004 Jul;45(7):1271; author reply 1271-2.

Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.超越剂量：利用治疗前生物标志物提高非霍奇金淋巴瘤放射免疫治疗结局的剂量预测。

Cancer Biother Radiopharm. 2017 Nov;32(9):309-319. doi: 10.1089/cbr.2017.2182. Epub 2017 Oct 30.

Biodistribution and kinetics of (131)I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma.（131）I标记的抗CD20单克隆抗体IDEC-C2B8（利妥昔单抗）在复发性非霍奇金淋巴瘤中的生物分布及动力学

Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1276-82. doi: 10.1007/s00259-002-0820-7. Epub 2002 Jul 6.

Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.肿瘤吸收剂量可预测¹³¹I-托西莫单抗放射免疫治疗后的无进展生存期。

J Nucl Med. 2014 Jul;55(7):1047-53. doi: 10.2967/jnumed.113.136044. Epub 2014 May 19.

Biological-effect modeling of radioimmunotherapy for non-hodgkins lymphoma: determination of model parameters.非霍奇金淋巴瘤放射免疫治疗的生物学效应建模：模型参数的确定

Cancer Biother Radiopharm. 2014 Feb;29(1):26-33. doi: 10.1089/cbr.2012.1467. Epub 2013 Oct 8.

引用本文的文献

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study.一种优化的长效生长抑素类似物用于转移性神经内分泌肿瘤肽受体放射性核素治疗的安全性、剂量学及疗效：从临床前试验到首次人体研究

Acta Pharm Sin B. 2025 Feb;15(2):707-721. doi: 10.1016/j.apsb.2024.05.022. Epub 2024 May 29.

Image quantification for radiation dose calculations--limitations and uncertainties.图像定量用于辐射剂量计算--局限性和不确定性。

Health Phys. 2010 Nov;99(5):688-701. doi: 10.1097/HP.0b013e3181e28cdb.

The effect of volume-of-interest misregistration on quantitative planar activity and dose estimation.感兴趣区配准误差对定量平面活性和剂量估计的影响。

Phys Med Biol. 2010 Sep 21;55(18):5483-97. doi: 10.1088/0031-9155/55/18/014. Epub 2010 Aug 27.

Effects of shortened acquisition time on accuracy and precision of quantitative estimates of organ activity.缩短采集时间对器官活动定量估计的准确性和精密度的影响。

Med Phys. 2010 Apr;37(4):1807-15. doi: 10.1118/1.3358119.

Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake.使用具有解剖结构和摄取量实际变化的体模群体评估用于器官活性和滞留时间估计的定量成像方法。

Med Phys. 2009 Feb;36(2):612-9. doi: 10.1118/1.3063156.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验